Cubist Pharmaceuticals, Inc. to Present at the Leerink Swann and Company Novel Antibiotic Conference

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that David McGirr, SVP and CFO, will present at the Leerink Swann & Company's Catching the Bug for Novel Antibiotics: Roundtable Conference, Tuesday, March 6, 2007, which is being held at the Le Parker Meridien Hotel in New York City. Mr. McGirr will participate in an expert panel discussion at 12:45 p.m. ET and also give a company presentation at 2:45 p.m. ET. The company presentation will include a discussion of the company’s business activities, financial outlook, and current news.
MORE ON THIS TOPIC